This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Ramos-Vara, J. A. Articles by Miller, M. A. Search for Related Content PubMed PubMed Citation Articles by Ramos-Vara, J. A. Articles by Miller, M. A. Social Bookmarking                            What's this?

Immunohistochemical Detection of Protein Gene Product 9.5 (PGP 9.5) in Canine Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides)

Animal Disease Diagnostic Laboratory and Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN

Protein gene product 9.5 (PGP 9.5), a ubiquitin COOH-terminal hydrolase initially considered specific for neural and neuroendocrine tissues, is expressed in a variety of epithelial and mesenchymal tumors. During immunohistochemical evaluation of a cutaneous epitheliotropic T-cell lymphoma (mycosis fungoides [MF]) in a dog, strong reactivity for PGP 9.5 was observed. This unexpected result prompted us to examine PGP 9.5 immunoreactivity in 13 additional cases of canine mycosis fungoides. All tumors were confirmed as T-cell epitheliotropic lymphoma by histopathology and immunohistochemistry for CD3. Eight of 14 cases were positive for PGP 9.5, with reactivity mainly in the cytoplasm and less commonly in the nucleus. One case had strong reactivity in the cell membrane, sometimes with concurrent paranuclear staining. Immunoreactivity did not correlate with location (epidermal, dermal, and adnexal) of tumor cells. Disease outcome did not vary between PGP 9.5-positive and negative tumors. Although PGP 9.5 immunoreactivity in MF did not predict tumor behavior in these dogs, it has had prognostic value in certain human carcinomas. This unexpected staining of lymphocytes in mycosis fungoides with an antibody to PGP 9.5 demonstrates its presence in nonneuroendocrine tumors and precludes its use as the sole diagnostic marker in discrete cell tumors in the skin.

Key words: CD3; CD79a; dogs; immunohistochemistry; lymphoma; mycosis fungoides; pathology; PGP 9.5.

Request reprints from Dr. José A Ramos-Vara, Animal Disease Diagnostic Laboratory, Purdue University, West Lafayette, IN 47907 (USA). E-mail: ramosja{at}purdue.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. A. Ramos-Vara, M. A. Miller, and V. E. O. Valli Immunohistochemical Detection of Multiple Myeloma 1/Interferon Regulatory Factor 4 (MUM1/IRF-4) in Canine Plasmacytoma: Comparison with CD79a and CD20 Vet. Pathol., November 1, 2007; 44(6): 875 - 884. [Abstract] [Full Text] [PDF]

				M. A. Owston and J. A. Ramos-Vara Histologic and Immunohistochemical Characterization of a Testicular Mixed Germ Cell Sex Cord-Stromal Tumor and a Leydig Cell Tumor in a Dog Vet. Pathol., November 1, 2007; 44(6): 936 - 943. [Abstract] [Full Text] [PDF]

				M. A. Miller, S. E. Hartnett, and J. A. Ramos-Vara Interstitial Cell Tumor and Sertoli Cell Tumor in the Testis of a Cat Vet. Pathol., May 1, 2007; 44(3): 394 - 397. [Abstract] [Full Text] [PDF]